VCCClogo
 
VCCC in the News
The Advocate Australia • Dec 2, 2020  0:19
Walter and Eliza Hall Institute researchers have discovered that the treatment of the most deadly form of blood ...
Eliza Hall Institute is the research powerhouse of the Victorian Comprehensive Cancer Centre, an alliance of leading Victorian hospitals and
 
The Advocate Australia • Dec 2, 2020  0:17
Scientists at the Walter and Eliza Hall Institute have created the first three-dimensional image of a key protein ...
and Eliza Hall Institute is the research powerhouse of the Victorian Comprehensive Cancer Centre (VCCC), an alliance of leading Victorian
 
 
Partners
Mirage News • Dec 4, 2020  16:18
The Illumina-University of Melbourne Genomics Hub will put the University’s researchers, students and precinct partners at the forefront of ...
revolution. Image: Professor Sean Grimmond and colleagues with a genome sequencer at the University of Melbourne Centre for Cancer Research
 
Oncology News Australia • Dec 1, 2020  23:2
A new study from the Universitat Pompeu Fabra, Barcelona, Spain, (UPF) and the Walter and Eliza Hall Institute of Medical Research ...
, Spain, (UPF) and the Walter and Eliza Hall Institute of Medical Research Melbourne, Australia, (WEHI) has described the role of p53 target
 
 
Grants
The Advocate Australia • Dec 2, 2020  0:18
Cancer Council Australia and the Clinical Oncology Society of Australia have called for new research into improved ...
Cancer Council Australia and the Clinical Oncology Society of Australia have called for new research into improved use of Australia’s
 
 
Blood Cancers
The Advocate Australia • Dec 2, 2020  0:18
STOMACH and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines ...
by the Australian National Health and Medical Research Council, the Ludwig Institute for Cancer Research and the Victorian Government.
 
The Sydney Morning Herald (Licensed by Copyright Agency) • Dec 1, 2020  11:21
For many cancer survivors, life is just as good as it is for those who have not had cancer. Research published on ...
Jefford, a medical oncologist at Melbourne's Peter MacCallum Cancer Centre and director of the Australian Cancer Survivorship Centre, said
 
Financial Review (Licensed by Copyright Agency) • Nov 30, 2020  11:3
Save Log in or Subscribe to save article Share Telix Pharmaceuticals has inked second deal in a month, after ...
snapping up Swiss-based biotech, TheraPharm GmbH. Elke Meitzel The Australian late-stage biotech is aiming to diagnose and treat various
 
 
Head and Neck
Department of Health • Nov 30, 2020  17:21
NT Health has released the final report of the Gunbalanya/Kakadu Disease Cluster Investigation.
operations. The investigation confirmed that the occurrence of head and neck cancers and lung cancer, and fetal deaths, were higher for
 
 
Lung Cancer
Proactive Investors Australia • Dec 1, 2020  9:39
The first-in-human, Phase 1, multi-centre, dose-escalation study of PD1-Vaxx is recruiting patients with non-small cell lung cancer.
with first patient dosed in Australia is a significant milestone for Imugene and clinicians treating Australians faced with the challenge of
 
 
Melanoma
The Advocate Australia • Dec 2, 2020  0:18
MELBOURNE researchers have revealed the critical importance of highly specialised immune cells, called natural ...
was supported by the Australian National Health and Medical Research Council, The Menzies Foundation and the Victorian Government. Source:
 
ABC News • Dec 1, 2020  5:47
Surfers, swimmers and stand-up paddle boarders are six times more likely to develop melanoma than the general population, researchers at ...
Council, Australia and New Zealand have the highest rates of melanoma in the world. More than 13,000 people are diagnosed in Australia
 
 
Pancreatic Cancer
Third Sector Magazine • Dec 1, 2020  14:19
PanKind , The Australian Pancreatic Cancer Foundation, will award $600 , 000 for Collaborative Research Grants in its 2020 grant ...
PanKind , The Australian Pancreatic Cancer Foundation, will award $600 , 000 for Collaborative Research Grants in its 2020 grant
 
 
Reproductive Cancers
Oncology News Australia • Dec 1, 2020  23:2
The Australian Clinical Trials Alliance (ACTA) has recognised the remarkable Australians who advance the health system through clinical ...
The Australian Clinical Trials Alliance (ACTA) has recognised the remarkable Australians who advance the health system through clinical
 
Pulse+IT Magazine • Nov 30, 2020  23:1
Australian Prostate Cancer Research has released a free iPhone app to help men better manage the difficult process of undergoing androgen ...
Australian Prostate Cancer Research has released a free iPhone app to help men better manage the difficult process of undergoing androgen
 
 
Treatment Development
The Morning Bulletin (Licensed by Copyright Agency) • Dec 4, 2020  17:0
THOSE battling one of the most common forms of Leukaemia will soon receive improved access to a revolutionary new ...
cancer, however it is the most common type of leukaemia diagnosed in Australia with around 1,000 people diagnosed each year,” Mr Hunt said.
 
HealthTimes • Dec 3, 2020  16:57
Photo: Cancer survivors Improved survival means cancer is increasingly a chronic disease, and a lot of people are living well with it, new ...
survivors. “There are more than one million people living with cancer in Australia and average five-year survival rates sit at 68 per cent,
 
The Advocate Australia • Dec 2, 2020  0:18
Cancer Council Australia and the Clinical Oncology Society of Australia have called for new research into improved ...
Cancer Council Australia and the Clinical Oncology Society of Australia have called for new research into improved use of Australia’s
 
 
Covid-19 & Cancer
The Australian • Dec 4, 2020  20:11
Super-survivor Pina Lee of Melbourne has been diagnosed with five different cancers over 14 years. Picture: Aaron Francis People who ...
 
PH News Hub • Dec 1, 2020  21:43
A new clinical trial aims to find out if cancer patients can safely self-administer COVID-19 tests at home rather than risk infection by ...
. Icon Group, Australia’s largest cancer care provider, has begun the study with patients in Queensland, New South Wales and Victoria. It